Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Sun Pharmaceutical Industries, Inc. with status Current. The shortage was first posted on Jul 14, 2023. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Sun Pharmaceutical Industries, Inc.
- Package NDC
- 57664-048-88
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88)
- Initial Posting
- Jul 14, 2023
Reason
Other